Martin Tolar is the founder of Alzheon. Alzheon has raised $50M in total funding. Latest round: Series D. Based in Framingham, Massachusetts.
Dr. Martin Tolar is the President and CEO of Alzheon, a clinical-stage biopharmaceutical company developing oral treatments for Alzheimer's disease and other neurodegenerative disorders. He has led the company through significant milestones, including raising $50 million in venture capital and completing the pivotal APOLLOE4 Phase 3 trial. He was awarded the Eliška and Zdenĕk Strmiska Award from the Alzheimer's Foundation for his contributions.
Full founder directory · Investor directory · Company funding database · Fundraising library